GenoMed is a Next Generation DM(tm) company that uses genomics to improve patient outcomes. DM (Disease Management) is the most important activity in healthcare, since it strives to improve clinical outcomes while lowering cost. GenoMed has discovered a "master" disease gene, which already has generic drugs available. GenoMed is the leader in finding disease-associated SNPs, and is currently developing new drugs for cancer.